Videos

Featured

Broadcast

Prevention & Chronic Conditions

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar , et al

Watch time: 1h 4m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
The Future of Heart Failure With Dr Yancy

Clyde W Yancy

Watch time: 9m 15s

Jasper J Brugts

Watch time: 2m 59s (15 videos)
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The POLY-HF Trial

Ambarish Pandey

Watch time: 4m 15s
ESC 25 Hot Line Discussion: VICTOR: Vericiguat in Heart Failure

Harriette Van Spall, Faiez Zannad

Watch time: 13m 4s
ESC HF 25: The VELOCITY Study

Stephen J Greene

Watch time: 5m 30s
ESC 25: The REBOOT-CNIC Trial

Borja Ibanez

Watch time: 3m 53s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m
ACC 2020: The VICTORIA Trial

Harriette Van Spall,

Watch time: 12m 47s
EMPERIAL in Review – Effects of Empagliflozin on Exercise Ability

William T Abraham

Watch time: 11m 27s
HFSA 2020: Spironolactone for Preventing Heart Failure

Watch time: 12m 43s
AHA 2020 Discussion: The EPIC-HF Trial

Larry A Allen, Harriette Van Spall

Watch time: 18m 54s
EHRA 2021: Long-Term Outcome of the RACE 3 Study

Michiel Rienstra, Bao Oanh Nguyen

Watch time: 8m 29s
Watch Now

Yassir Javaid

Watch time: 12m 6s
Watch Now

Carlos Juanatey

Watch time: 9m 50s
ACC 22: MAVA-LTE Shows Improvement in NYHA Class in Patients Treated with Mavacamten

Florian Rader

Watch time: 7m 19s
APSC Journal Club - Role of SGLT2i in HFpEF and Its Impact on Renal Outcomes

Jack Tan Wei Chieh, Jonathan Jiunn Liang Yap, James Xu , et al

Watch time: 1h 3m 53s
HF 22: Ghrelin-HF: Intravenous Ghrelin In Patients with HFpEF

Lars H Lund

Watch time: 5m 11s
ESC 22: 3 Trials That Will Change Your Practice With Dr Alasnag

Mirvat Alasnag

Watch time: 6m 50s
JAPSC Mohamed Supplement 2

Riyadh Qasim

Watch time: 2s
AHA 22: 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag

Mirvat Alasnag

Watch time: 12m 38s
ACC 23: Mechanism of Benefit for Dapagliflozin in HFpEF

Barry Borlaug

Watch time: 5m 21s
EHRA 23: ANTWOORD II: LVEF Recovery After AF Ablation in HF Patients

Marco Bergonti

Watch time: 6m 26s
View from the Thoraxcenter: ESC 23 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen

Watch time: 28m 31s